Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001628280-16-014057
Filing Date
2016-04-05
Accepted
2016-04-05 16:56:03
Documents
1
Period of Report
2015-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 3/A wf-form3a_145988975254345.html 3/A  
1 FORM 3/A wf-form3a_145988975254345.xml 3/A 2605
  Complete submission text file 0001628280-16-014057.txt   3985
Mailing Address 101 HUDSON STREET SUITE 3610 JERSEY CITY NJ 07302-6548
Business Address 101 HUDSON STREET SUITE 3610 JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Issuer) CIK: 0001178253 (see all company filings)

EIN.: 562181648 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SCYNEXIS, INC. 3501 C TRICENTER BOULEVARD DURHAM NC 27713
Business Address
Angulo Gonzalez David (Reporting) CIK: 0001644071 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-36365 | Film No.: 161555204